Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Duration of anticoagulation for venous thromboembolism in pediatric patients: Evaluation of the Duration of Therapy for Thrombosis in Children (Kids-DOTT) trial outcomes at 2 years

Journal of Thrombosis and Haemostasis(2024)10.1016/j.jtha.2024.09.038Source: DataRank Database

Duration of anticoagulation for venous thromboembolism in pediatric patients: Evaluation of the Duration of Therapy for Thrombosis in Children (Kids-DOTT) trial outcomes at 2 years is a research paper published in Journal of Thrombosis and Haemostasis (2024). On theSindex it has a DataRank of 0. It has been cited 8 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access8 citations

Download PDF

Cite:

Linked data & code

nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 2.36)OA: bronzeTopics (32)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (83)

Sam Schulman ORCID,John M. Kittelson,Thomas C. Abshire ORCID,James F. Casella ORCID,Rita Dale

Live enrichment

PubMed:39461724 PMC:PMC11786982 OpenAlex:https://openalex.org/W4403711785

American Society of Hematology

Grant: 2020-2024

American Society of Hematology

Grant: 2016-2024

National Heart, Lung, and Blood Institute

Grant: K23HL084055

Johns Hopkins All Children's Foundation

Grant: K-to-R

NHLBI NIH HHS

Grant: U01 HL130048

FWCI

2.36

Citation Percentile

0.9%

Citation Trend

2025

2026

bronzeLicense: http://www.elsevier.com/open-access/userlicense/1.0/

journalhttps://www.jthjournal.org/article/S1538-7836(24)00631-7/pdf

publisherhttps://www.jthjournal.org/article/S1538-7836(24)00631-7/pdf

publisherhttps://api.elsevier.com/content/article/PII:S1538783624006317?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1538783624006317?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.jtha.2024.09.038

Fields of Study

Blood Coagulation and Thrombosis MechanismsVenous Thromboembolism Diagnosis and ManagementHeparin-Induced Thrombocytopenia and Thrombosis

MeSH Terms

Duration of TherapyAdolescentAge FactorsAnticoagulantsChildChild, PreschoolDrug Administration ScheduleFemaleHemorrhageHumansInfantMaleRecurrenceRisk FactorsTime FactorsTreatment OutcomeVenous ThromboembolismYoung Adult

Keywords

Venous thromboembolismMedicineDuration (music)PediatricsIntensive care medicineInternal medicineThrombosisChildrenAnticoagulationTreatmentDuration

Sustainable Development Goals

SDG 0: Good health and well-being

Duration of anticoagulation for venous thromboembolism in pediatric patients: Evaluation of the Duration of Therapy for Thrombosis in Children (Kids-DOTT) trial outcomes at 2 years

FAIR Checklist

Authors (83)

Funding (5 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)